» Articles » PMID: 35370967

Relationship Between Acylcarnitine and the Risk of Retinopathy in Type 2 Diabetes Mellitus

Overview
Specialty Endocrinology
Date 2022 Apr 4
PMID 35370967
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Diabetic retinopathy is a common complication of type 2 diabetes mellitus (T2DM). Due to the limited effectiveness of current prevention and treatment methods, new biomarkers are urgently needed for the prevention and diagnosis of DR. This study aimed to explore the relationships between plasma acylcarnitine with DR in T2DM.

Methods: From May 2015 to August 2016, data of 1032 T2DM patients were extracted from tertiary hospitals. Potential non-linear associations were tested by binary logistic regression models, and ORs and 95% CIs of the research variables were obtained. Correlation heat map was used to analyze the correlation between variables. The change of predictive ability was judged by the area under the receiver operating characteristic curve.

Results: Of the 1032 patients with T2DM, 162 suffered from DR. After adjusting for several confounding variables, C2 (OR:0.55, 95%CI:0.39-0.76), C14DC (OR:0.64, 95%CI:0.49-0.84), C16 (OR:0.64, 95%CI:0.49-0.84), C18:1OH (OR:0.51, 95%CI:0.36-0.71) and C18:1 (OR:0.60, 95%CI:0.44-0.83) were negatively correlated with DR. The area under the curve increased from 0.794 (95% CI 0.745 to 0.842) to 0.840 (95% CI 0.797 to 0.833) when C2, C14DC, C18:1OH and C18:1 added to the traditional risk factor model.

Conclusion: There was a negative correlation between C2, C14DC, C16, C18:1OH, and C18:1 and the risk of retinopathy in patients with T2DM. C2, C14DC, C18:1OH, and C18:1 may be new predictors and diagnostic markers of DR.

Citing Articles

Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation.

Xiang F, Zhang Z, Xie J, Xiong S, Yang C, Liao D J Transl Med. 2025; 23(1):324.

PMID: 40087749 DOI: 10.1186/s12967-025-06341-5.


Screening and evaluation of diabetic retinopathy a deep learning network model: A prospective study.

Yao L, Cao C, Yu G, Shu X, Fan X, Zhang Y World J Diabetes. 2024; 15(12):2302-2310.

PMID: 39676804 PMC: 11580591. DOI: 10.4239/wjd.v15.i12.2302.


Explainable Artificial Intelligence Paves the Way in Precision Diagnostics and Biomarker Discovery for the Subclass of Diabetic Retinopathy in Type 2 Diabetics.

Yagin F, Yasar S, Gormez Y, Yagin B, Pinar A, Alkhateeb A Metabolites. 2023; 13(12).

PMID: 38132885 PMC: 10745306. DOI: 10.3390/metabo13121204.


Adverse effects of type 2 diabetes mellitus on ovarian reserve and pregnancy outcomes during the assisted reproductive technology process.

Qin X, Du J, He R, Li Y, Zhu Q, Li Y Front Endocrinol (Lausanne). 2023; 14:1274327.

PMID: 38033999 PMC: 10686411. DOI: 10.3389/fendo.2023.1274327.


An early prediction model for gestational diabetes mellitus based on metabolomic biomarkers.

Razo-Azamar M, Nambo-Venegas R, Meraz-Cruz N, Guevara-Cruz M, Ibarra-Gonzalez I, Vela-Amieva M Diabetol Metab Syndr. 2023; 15(1):116.

PMID: 37264408 PMC: 10234027. DOI: 10.1186/s13098-023-01098-7.


References
1.
Houten S, Wanders R, Ranea-Robles P . Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism. Biochim Biophys Acta Mol Basis Dis. 2020; 1866(5):165720. PMC: 7146961. DOI: 10.1016/j.bbadis.2020.165720. View

2.
Luo H, Li J, Feng X, Sun X, Li J, Yang X . Plasma phenylalanine and tyrosine and their interactions with diabetic nephropathy for risk of diabetic retinopathy in type 2 diabetes. BMJ Open Diabetes Res Care. 2020; 8(1). PMC: 7473660. DOI: 10.1136/bmjdrc-2019-000877. View

3.
Schooneman M, Vaz F, Houten S, Soeters M . Acylcarnitines: reflecting or inflicting insulin resistance?. Diabetes. 2012; 62(1):1-8. PMC: 3526046. DOI: 10.2337/db12-0466. View

4.
Bene J, Hadzsiev K, Melegh B . Role of carnitine and its derivatives in the development and management of type 2 diabetes. Nutr Diabetes. 2018; 8(1):8. PMC: 5856836. DOI: 10.1038/s41387-018-0017-1. View

5.
Guasch-Ferre M, Zheng Y, Ruiz-Canela M, Hruby A, Martinez-Gonzalez M, Clish C . Plasma acylcarnitines and risk of cardiovascular disease: effect of Mediterranean diet interventions. Am J Clin Nutr. 2016; 103(6):1408-16. PMC: 4881000. DOI: 10.3945/ajcn.116.130492. View